VivaGel condom receives TGA device certification
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- Starpharma receives $4.2M R&D tax incentive refund
- SPP Record Date Clarification
- SPL: VivaGel condom approved for sale with launch imminent
- DEP docetaxel - longer duration and increased exposure
Later from Starpharma
- ARC grant for Starpharmas targeted drug delivery
- Reduced neurotoxicity - SPLs dendrimer enhanced oxaliplatin
- SPLs dendrimer a potential viral conjunctivitis treatment
- SPL Signs Priostar Agrochemical Partnership with Gowan
- Starpharma Dendrimer-Docetaxel eliminates neutropenia
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma